Expression of erbB-3 protein in colorectal adenocarcinoma: Correlation with poor survival

Journal of Cancer Research and Clinical Oncology

Volumn 126, Issue 4, 2000, Pages 205-211

  Kapitanović, Sanja ^a   Radošević, Senka ^b   Slade, Neda ^a   Kapitanović, Milan ^c   Andelinović, Šimun ^d   Ferenčić, Željko ^b   Tavassoli, Mahvash ^e   Spaventi, Šime ^f   Pavelić, Krešimir ^a   Spaventi, Radan ^a,b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b PLIVA Research Institute Ltd   (Croatia)

^c Department of Surgery   (Croatia)

^d UNIVERSITY HOSPITAL SPLIT   (Croatia)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f CROATIAN ACADEMY OF SCIENCES AND ARTS   (Croatia)

Author keywords

Colorectal carcinoma; erbB 3; Prognosis; Survival

Indexed keywords

GLYCOPROTEIN; MEMBRANE PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0034037423     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050034     Document Type: Article

References (33)

1. Alroy I, Yarden Y (1997) The erbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 410: 83-86
2. Bargmann CI, Hung MC, Weinberg RA (1986) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45: 649-657
3. Bargmann CI, Weinberg RA (1988) Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J 17: 2043-2052
4. Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, Garrigues J, Radke S, Todaro GJ, Salomon DS (1991) Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci USA 88: 7792-7796
5. Coussens L, Yang-Feng YL, Liao Y-C, Chen E, Gray A, McGrath J, Seenburg PH, Levinson A, Ullrich A (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal localization with neu oncogene. Science 230: 1132-1185
6. Deans GT, Parks TG, Rowlands BJ, Spence RAJ (1992) Prognostic factors in colorectal cancer. Br J Surg 79: 608-613
7. Friess H, Yamanaka Y, Kobrin MS, Do DA, Buchler MW, Korc M (1995) Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. Clin Cancer Res 1: 1413-1420
8. Funayama T, Nakanishi T, Takahashi K, Taniguchi S, Takigawa M, Matsumurs T (1998) Overexpression of c-erbB-3 in various stages of human squamous cell carcinomas. Oncology 55: 161-167
9. Grunt TW, Huber H (1994) The family of c-erbB genes: from basic research to clinical oncology. Onkologie 17: 346-357
10. Hollywood DP, Hurst HC (1993) A novel transcription factor, OB-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumor lines. EMBO J 12: 2369-2375
11. Ibrahim SO, Vasstrand EN, Liavang PG, Johannessen AC, Lillehaug JR (1997) Expression of erbB proto-oncogene family members in squamous cell carcinoma of the head and neck. Anticancer Res 17: 4539-4546
12. Kapitanović S, Spaventi R, Poljak L, Kapitanović M, Pavelić ZP, Gluckman JL, Spaventi Š, Pavelić K (1994) High c-erbB-2 protein level in colorectal adenocarcinomas correlates with clinical parameters. Cancer Detect Prev 18: 97-101
13. Kapitanović S, Radošević S, Kapitanović M, Andelinović, Ferenčić Z, Tavassoli M, Primorac D, Sonicki Z, Spaventi Š, Pavelić K, Spaventi R (1997) The expression of p185HER-2/neu correlates with the stage of disease and survival in colorectal cancer. Gastroenterology 112: 1103-1113
14. Kay EW, Mulcahy H, Walsh CB, Leader M, O'Donoghue D (1994) Cytoplasmatic c-erbB-2 protein expression correlates with survival in Dukes' B colorectal carcinoma. Histopathology 25: 455-461
15. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA (1989) Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86: 9193-9197
16. Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ, Hurst HC (1992a) Expression of the ERBB3 gene product in breast cancer. Br J Cancer 66: 1116-1121
17. Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Kleppel G (1992b) The c-erbB-3 gene in human pancreatic cancer. J Pathol 168: 269-273
18. Maurer CA, Freiss H, Kretschmann B, Zimmermann A, Stauffer A, Baer HU, Korc M, Buchler MW (1998) Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Hum Pathol 29: 771-777
19. Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todaro GJ, Shoyab M (1990) Molecular cloning and expression of an additional epidermal growth factor receptorrelated gene. Proc Natl Acad Sci USA 87: 4905-4909
20. erbB4. Nature 366: 473-475
21. Poller DN, Spendolve I, Baker C, Church R, Ellis IO, Plowman GD, Mayer RJ (1992) Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas. J Pathol 168: 275-280
22. Quinn CM, Ostrowski JL, Lane SA, Loney DP, Teasdale J, Benson EA (1994) c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival. Histopathology 25: 247-252
23. Rajkumar T, Goden CSR, Lemoine NR, Gullick WJ (1993) Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1. J Pathol 170: 271-278
24. Rajkumar T, Hollywood DP, Hurst HC, Gullick WJ (1995) c-erbB3 expression in breast tumour derived cell lines. Breast 4: 84-91
25. Sanidas EE, Filipe MI, Linehan J, Lemoine NR, Gullick WJ, Rajkumar T, Levison DA (1993) Expression of the c-erbB-3 gene product in gastric cancer. Int J Cancer 54: 935-940
26. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182
27. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SA, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712
28. Spaventi R, Pečur L, Pavelić K, Pavelić Z, Spaventi Š, Stambrook P. (1994) Human tumour bank in Croatia: a possible model for a small bank as part of the future european tumour bank network. Eur J Cancer 30A: 419
29. Turnbull RB, Kyle K, Watson FR (1967) Cancer of the rectum: The influence of the no-touch isolation technique on survival rates. Ann Surg 166: 420-427
30. Tzahar E, Yarden Y (1998) The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. Biochim Biophys Acta 1377: M25-M37
31. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986) Similarity of protein encoded by human c-erbB-2 gene to epidermal growth factor receptor. Nature 319: 230-234
32. Yi ES, Harclerode D, Gondo M, Stephenson M, Brown RW, Younes M, Cagle PT (1997) High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinoma. Mod Pathol 10: 142-148
33. Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M, Sasaki T (1991) Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis is gastric cancer. Cancer Res 51: 1034-1038